Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole

阿立哌唑 青少年躁狂量表 情感障碍症 安慰剂 双相情感障碍 狂躁 心理学 内科学 嗜睡 医学 不利影响 精神科 精神分裂症(面向对象编程) 心情 病理 替代医学
作者
Robert L. Findling,Margaretta Nyilas,Robert A. Forbes,Robert D. McQuade,Na Jin,Taro Iwamoto,Svetlana А. Ivanova,William H. Carson,Kiki D. Chang
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:70 (10): 1441-1451 被引量:172
标识
DOI:10.4088/jcp.09m05164yel
摘要

Article AbstractObjectives: To determine the efficacy and safety of aripiprazole for the treatment of pediatric bipolar I disorder, manic or mixed episode, with or without psychotic features. Method: Subjects were enrolled between March 2005 and February 2007 in a randomized, multicenter, double-blind 4-week study of aripiprazole 10 mg/d, aripiprazole 30 mg/d, and placebo. Subjects (n = 296) were 10 to 17 years old with a DSM-IV diagnosis of bipolar I disorder with current manic or mixed episodes, with or without psychotic features, and a Young Mania Rating Scale (YMRS) score ≥ 20. The primary efficacy variable was change from baseline in the YMRS total score. Results: Both doses of aripiprazole were superior to placebo on the YMRS total score beginning at week 1 and continuing through week 4. Aripiprazole 10 mg and 30 mg were more effective than placebo on global improvement, mania, and overall bipolar illness outcome measures. Response (≥ 50% reduction in YMRS total score) at week 4 was achieved by 44.8%, 63.6%, and 26.1% of subjects in the aripiprazole 10 mg, aripiprazole 30 mg, and placebo groups, respectively (P < .01 both doses vs placebo). Both doses were generally well tolerated. The most common adverse events were extrapyramidal disorder and somnolence; rates were higher for aripiprazole 30 mg compared with aripiprazole 10 mg. Average weight gain was not significantly different between the aripiprazole 10 mg (+0.82 kg) or 30 mg (+1.08 kg) groups compared with the placebo group (+0.56 kg) (P = .35 and P = .13, respectively). Conclusions: Aripiprazole in daily doses of 10 mg or 30 mg is an effective and generally well-tolerated acute treatment for pediatric subjects with bipolar I mania or mixed episodes. Trial Registration: clinicaltrials.gov Identifier: NCT00110461 Submitted: February 23, 2009; accepted July 10, 2009. Corresponding author: Robert L. Findling, MD, Department of Psychiatry, Division of Child and Adolescent Psychiatry, University Hospitals Case Medical Center, Case Western Reserve University, 10524 Euclid Ave-1st Floor, Cleveland, OH 44106 (robert.findling@uhhospitals.org).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
谨慎的从灵完成签到,获得积分10
1秒前
1秒前
自由的惮完成签到,获得积分20
2秒前
2秒前
xiaoxiao33完成签到,获得积分10
3秒前
4秒前
烛黎完成签到,获得积分10
5秒前
YaoHui完成签到,获得积分10
5秒前
5秒前
66完成签到,获得积分10
6秒前
孔晓辉完成签到,获得积分20
6秒前
6秒前
慕青的应助被GeoGou812采纳,获得30
7秒前
wcl完成签到,获得积分10
7秒前
7秒前
薄荷薄荷发布了新的文献求助30
7秒前
新XX完成签到,获得积分10
7秒前
wy.he完成签到,获得积分0
7秒前
高挑的白旋风完成签到,获得积分10
7秒前
sjy完成签到,获得积分20
8秒前
essieyang发布了新的文献求助10
8秒前
8秒前
美满的问儿完成签到,获得积分10
8秒前
super chan发布了新的文献求助10
9秒前
10秒前
谦让晓露as完成签到,获得积分10
10秒前
10秒前
台台a发布了新的文献求助30
10秒前
赘婿的应助被辛勤的乌采纳,获得10
11秒前
fanzixuan完成签到,获得积分20
11秒前
Connor完成签到,获得积分10
11秒前
12秒前
12秒前
13秒前
syngman发布了新的文献求助10
13秒前
369ninja的应助被搞怪的乐荷采纳,获得10
14秒前
wwwwwcy发布了新的文献求助10
14秒前
敛袂完成签到,获得积分10
15秒前
英吉利25发布了新的文献求助10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153573
求助须知:如何正确求助?哪些是违规求助? 9550279
关于积分的说明 21697424
捐赠科研通 7742161
什么是DOI,文献DOI怎么找? 3425546
关于科研通互助平台的介绍 2550636
邀请新用户注册赠送积分活动 2469181